SanofiSNYNASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank71
3Y CAGR+3.0%
5Y CAGR+0.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+3.0%/yr
vs -3.0%/yr prior
5Y CAGR
+0.3%/yr
Consistent
Acceleration
+5.9pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
3 yr
Consecutive growthStable
PeriodValueYoY Change
2025$9.54B+3.9%
2024$9.18B+2.8%
2023$8.93B+2.2%
2022$8.74B-8.5%
2021$9.55B+1.7%
2020$9.39B-5.0%
2019$9.88B+0.3%
2018$9.86B-2.1%
2017$10.07B+6.3%
2016$9.48B-